Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Anti-HIV Therapy Boosts Life Expectancy

Anti-HIV Therapy Boosts Life Expectancy

July 28, 2008

BIRMINGHAM, Ala. - The life expectancy for patients with human immunodeficiency virus (HIV) has increased by more than 13 years since the late 1990s thanks to advancements in antiretroviral therapy, according to researchers at the University of Alabama at Birmingham (UAB) and Simon Fraser University in Vancouver, British Columbia.

Improved survival has led to a nearly 40 percent drop in AIDS deaths among 43,355 HIV-positive study participants in Europe and North America, bolstering the call for improved anti-HIV efforts worldwide, the study authors said.




The study is published in the British medical journal The Lancet. It was compiled by The Antiretroviral Therapy Cohort Collaboration, which includes UAB, Simon Fraser University and more than a dozen other research sites around the world.

COCKTAIL OF DRUGS

The authors looked at changes in life expectancy and mortality among the 43,355 HIV patients taking a cocktail of drugs called combination antiretroviral therapy (cART). Data was compiled from a total of 14 studies in Europe and North America.

"Since their introduction in 1996 cART regimens have become more effective, better tolerated and easier to follow," said Michael Mugavero, M.D., an assistant professor in UAB's Division of Infectious Diseases and a co-author on the study.

"We are now seeing the benefits of years of research, hard work and efforts to make these medications widely available. This has led to dramatic improvements in life expectancy, but patients who start cART with more advanced HIV infection do not have the same level of benefit," Mugavero said.

The new Lancet study found cART yielded a 13.8-year life-expectancy increase - from 36.1 years in study participants who began therapy during the 1996-1999 period to 49.9 years in participants who began therapy during the 2003-2005 period.

Despite the good results, the study found life expectancy for HIV patients is far lower on average than the general population, which includes all those with other chronic illnesses. For example, an HIV-positive patient starting cART at age 20 will live to 63, about 20 years shorter than the average life span of non-infected adults.

With nearly half of all patients diagnosed with advanced HIV infection, the life expectancy benefits of cART are not fully realized, said Mugavero and lead study author Robert Hogg, Ph.D., of Simon Fraser University. Improved AIDS testing and increased access to care is needed.

Funding from the study came from the UK Research Council and from GlaxoSmithKline.

University of Alabama at Birmingham



Related Life Expectancy Current Events and Life Expectancy News Articles Life Expectancy Current Events and Life Expectancy News RSS Life Expectancy Current Events and Life Expectancy News RSS
Studies examine quality of care for hospitalized sickle cell disease patients
A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings will be presented at a press conference on Saturday, December 6, at 9:30 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA.

Drop in cancer deaths tied primarily to gains in behavior and screening
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.

Women with Mitral Valve Prolapse are Treated Less Aggressively Than Men and May be at High Risk
Disturbing evidence of higher mortality and lower surgery rates in women versus men with mitral valve prolapse and severe leakage may be related to the complexity of evaluating the condition's severity in women, according to findings of a Mayo Clinic study published this month in the Annals of Internal Medicine.

Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding
A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding.

3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), disrupt the quality of life for patients, put a tremendous burden on family caregivers, and cost society billions of dollars annually.

Study: Elderly Women Can Increase Strength But Still Risk Falls
Elderly women can increase muscle strength as much as young women can, a new study from the University of New Hampshire finds, indicating that decline in muscle function is less a natural part of the aging process than due to a decline in physical activity.

Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/).

Treatment window expanded
Patients can still benefit up to 4.5 hours after a stroke if a drug that dis-solves blood clots in the brain is administered. Thus far, three hours had been considered the useful limit for administering thrombolytic drugs.

Study examines cost-effectiveness of HIV monitoring strategy in countries with limited resources
In a computer-based model evaluating the benefits and costs of three types of HIV disease monitoring strategies, early initiation of antiretroviral therapy and monitoring using the CD4 count, a measure of immune system function, instead of based on symptoms appear to provide health benefits in low- and middle-income countries.

Depressed dialysis patients more likely to be hospitalized or die, researcher finds
Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.
More Life Expectancy Current Events and Life Expectancy News Articles


Life Expectancy
by Dean Koontz

With his bestselling blend of nail-biting intensity, daring artistry, and storytelling magic, Dean Koontz returns with an emotional roller coaster of a tale filled with enough twists, turns, shocks, and surprises for ten ordinary novels. Here is the story of five days in the life of an ordinary man born to an extraordinary legacy—a story that will challenge the way you look at good and evil,...



Rising Life Expectancy: A Global History
by James C. Riley

Between 1800 and 2000 life expectancy at birth rose from about 30 years to a global average of 67 years, and to more than 75 years in favored countries. This dramatic change was called a health transition, characterized by a transition both in how long people expected to live, and how they expected to die. Rising Life Expectancy examines the way humans reduced risks to their survival, both...



Diet, Life Expectancy, and Chronic Disease: Studies of Seventh-Day Adventists and Other Vegetarians
by Gary E. Fraser

Text analyzes the results of studies on Seventh-day Adventists and other vegetarian groups focusing on the role of diet in chronic disease. Benefits of a vegetarian diet and the effects of individual foods on disease risk and longevity are discussed in detail. Addresses cancer rates, coronary heart disease, and the challenge of nutritional...



Life Expectancy in Court: A Textbook for Doctors and Lawyers
by T. W. Anderson

Life expectancy is an important issue in cases of serious personal injury. This book explains how to calculate life expectancy, and how to avoid common mistakes and misunderstandings. Basic concepts are illustrated with data from studies involving a wide range of conditions, including alcoholism, cerebral palsy, colon cancer, diabetes, and spinal cord injury (tetraplegia). There are also case...

Life Expectancy
by Dean R Koontz



Life Expectancy
by Dean R. Koontz

Life Expectancy
by Dean R. Koontz

Estimating Healthy Life Expectancies Using Longitudinal Survey Data: Methods and Techniques in Population Health Measures (Vital and Health Statistics)

Life Expectancy
by Dean Koontz



Life Expectancy
by Dean Koontz

© 2009 BrightSurf.com